NorthWest Biotherapeutics Inc (NWBO)

[CrashOverride]

NWBO will go 10,000% in a very short amount of time on approval news in all four trial jurisdictions. We are worth well over $30. In fact we will be around $42-47 depending on if we get approval for all high grade brain cancers in addition to newly-diagnosed and recurrent Glioblastoma. Being able to meet this demand with Flaskworks will most certainly support that valuation. The math isn't up for debate. Those who argue the opposite with pending federal civil litigation should know these matters can be referred to federal law enforcement and interpol quite easily.